Have a personal or library account? Click to login
An overview of the Progenika ID CORE XT: an automated genotyping platform based on a fluidic microarray system Cover

An overview of the Progenika ID CORE XT: an automated genotyping platform based on a fluidic microarray system

Paid access
|Oct 2019

Abstract

Automated testing platforms facilitate the introduction of red cell genotyping of patients and blood donors. Fluidic microarray systems, such as Luminex XMAP (Austin, TX), are used in many clinical applications, including HLA and HPA typing. The Progenika ID CORE XT (Progenika Biopharma-Grifols, Bizkaia, Spain) uses this platform to analyze 29 polymorphisms determining 37 antigens in 10 blood group systems. Once DNA has been extracted, processing time is approximately 4 hours. The system is highly automated and includes integrated analysis software that produces a file and a report with genotype and predicted phenotype results. Immunohematology2015;31:62–68.

DOI: https://doi.org/10.21307/immunohematology-2019-072 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 62 - 68
Published on: Oct 26, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2019 M. Goldman, N. Nogués, L.M. Castilho, published by American National Red Cross
This work is licensed under the Creative Commons License.